ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Atraumatic Rotator Cuff Rupture in Elderly Patients (toarcriep)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01116518
Recruitment Status : Completed
First Posted : May 5, 2010
Last Update Posted : November 26, 2013
Sponsor:
Collaborators:
Tampere University Hospital
Kuopio University Hospital
Information provided by (Responsible Party):
Ville Aarimaa, Turku University Hospital

Brief Summary:
The purpose of the investigators study is to compare the effect of: 1) physiotherapy 2) arthroscopic acromioplasty and debridement or 3) arthroscopic rotator cuff reconstruction and acromioplasty in the treatment of degenerative, atraumatic rotator cuff rupture.

Condition or disease Intervention/treatment Phase
Atraumatic Rotator Cuff Rupture Procedure: physiotherapy Procedure: acromioplasty Procedure: acromioplasty and rotator cuff reconstruction Not Applicable

Detailed Description:

The study will be conducted according to the revised Declaration of Helsinki by The World Medical Association and the ICH-guidelines for good clinical trial practice. The study will be submitted for approval to the Ethics Committee of the Hospital District of Varsinais-Suomi, Finland. A written informed consent will be obtained from each patient.

This study will be conducted at three different hospitals i.e. Turku University Hospital, Tampere University Hospital (Hatanpää hospital) and Kuopio University Hospital as a multicenter study. A total of 180 patients, 60 patients at each hospital, will be included in this study. The patients are clinically examined and a routine x-ray and MRI-investigation are performed. Patients must have an atraumatic degenerative supraspinatus tendon rupture comprising less than 2/3 of the tendon insertion, i.e. 1/3 of the tendon insertion must be intact. The rupture must be documented by MRI investigation. Patients must be willing and give a written informed consent. After recruitment the patients are randomized in one of three studied treatment modalities. The randomization is made after clinical and MRI investigation by neutral attendant using sealed envelopes. 60 identical envelopes (20 per group) are made in each center.

The Constant score is used as a primary outcome measure. The Constant score is measured from each patient right before treatment intervention and at three and six months, one, two and five years after the intervention. The intervention groups are designed in a cumulative fashion: structured and standardized physiotherapy treatment proceeds gradually in all patients (groups 1,2,3), in addition to physiotherapy patients in group 2 are treated with acromioplasty, and patients in group 3 with acromioplasty and rotator cuff reconstruction.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 180 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Treatment of Atraumatic Rotator Cuff Rupture in Elderly Patients
Study Start Date : February 2009
Actual Primary Completion Date : November 2013
Actual Study Completion Date : November 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tears
U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: physiotherapy Procedure: physiotherapy
Active Comparator: acromioplasty Procedure: acromioplasty
Active Comparator: acromioplasty and rotator cuff reconstruction Procedure: acromioplasty and rotator cuff reconstruction



Primary Outcome Measures :
  1. Shoulder score by Constant and Murley [ Time Frame: 2 years ]
    Constant scoring is endorsed by SECEC/ESSSE and is the most largely used instrument measuring shoulder pain, function and strenght. This scoring system is very suited for evaluating disability caused by rotator cuff ruptures.

  2. Constant score
    subjective and objective shoulder score



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. age over 55 years
  2. atraumatic penetrating supraspinatus tendon rupture comprising less than 2/3 of the tendon insertion and documented with MRI investigation.
  3. full active range of motion
  4. written informed consent from participating subject

Exclusion Criteria:

  1. age under 55 years
  2. existing significant malignant, haematological, endocrine, metabolic, rheumatoid or gastrointestinal disease
  3. cytostatic or corticosteroid medication
  4. glenohumeral osteoarthrosis grade III or above (X-ray evaluation with present osteophytes according to Kellgren-Lawrence classification)
  5. history of alcoholism, drug abuse, psychological or other emotional problems that are likely to invalidate informed consent
  6. previous same shoulder surgery
  7. a massive tendon tear involving the whole supraspinatus tendon and/or combined tear of two - three tendons ie. supraspinatus with infraspinatus or subscapularis tendon tear.
  8. patients denial

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01116518


Locations
Finland
Kuopio University Hospital
Kuopio, Finland, 70211
Tampere University Hospital
Tampere, Finland, 33101
Turku University Hospital
Turku, Finland, 20701
Sponsors and Collaborators
Turku University Hospital
Tampere University Hospital
Kuopio University Hospital
Investigators
Principal Investigator: Juha Kukkonen, MD Turku University Hospital
Study Director: Ville Äärimaa, MD, PhD Turku University Hospital

Responsible Party: Ville Aarimaa, Ville Äärimaa, Turku University Hospital
ClinicalTrials.gov Identifier: NCT01116518     History of Changes
Other Study ID Numbers: 106/2007
First Posted: May 5, 2010    Key Record Dates
Last Update Posted: November 26, 2013
Last Verified: May 2010

Additional relevant MeSH terms:
Rupture
Rotator Cuff Injuries
Wounds and Injuries
Shoulder Injuries
Tendon Injuries